IP Library Granted Patent US 7,384,982
Granted Patent B2
US 7,384,982 · App. 10/615,213 · Granted Jun 10, 2008

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,384,982
App. No.
10/615,213
Granted
Jun 10, 2008
Kind
B2
Abstract

The inventors have discovered that the disodium salt of certain delivery agents has surprisingly greater efficacy for delivering active agents than the corresponding monosodium salt. Furthermore, the inventors have discovered that the disodium salts of these delivery agents form solvates with ethanol and hydrates with water. The delivery agents have the formula wherein R 1 , R 2 , R 3 , and R 4 are indepedently hydrogen, halogen, C 1 -C 4 alkyl, or C 1 -C 4 alkoxy; and R 5 is a substitued or unsubstituted C 2 -C 16 alkylene, substituted or unsubstituted C 2 -C 16 alkenylene, substituted or unsubstituted C 1 -C 12 alkyl(arylene), or substituted or unsubstituted aryl(C 1 -C 12 alkylene). The hydrates and solvates of present invention also have surprisingly greater efficacy for delivering active agents, such as heparin and calcitonin, than their corresponding monosodium salts and free acids. The present invention provides an alcohol solvate, such as ethanol solvate, of a disodium salt of a delivery agent of the formula above. The invention also provides a hydrate of a disodium salt of a delivery agent of the formula above. Preferred delivery agents include, but are not limited to, N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC), N-(10-[2-hydroxybenzoyl]amino)decanoic acid (SNAD), and sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC). The invention also provides methods of preparing the disodium salt, ethanol solvate, and hydrate and compositions containing the disodium salt, ethanol solvate, and/or hydrate.

Claims (7)

1. A method for administering salmon calcitonin to an animal in need thereof, the method comprising administering orally to the animal a composition comprising:

(a) N-(5-chlorosalicyloyl)-8-aminocaprylic acid, wherein N-(5-chlorosalicyloyl)-8-aminocaprylic acid comprises at least about 96% by weight of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid; and

(b) salmon calcitonin.

2. The method of claim 1 , wherein the animal is a human.

3. A method for administering calcitonin to an animal in need thereof, the method comprising administering orally to the animal a composition comprising:

(a) N-(5-chlorosalicyloyl)-8-aminocaprylic acid, wherein N-(5-chlorosalicyloyl)-8-aminocaprylic acid comprises at least about 90% by weight of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid; and

(b) calcitonin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2021
From: EMISPHERE TECHNOLOGIES, INC.
To: NOVO NORDISK NORTH AMERICA OPERATIONS A/S
Reel/Frame 056750/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2006
From: AZRIA, MOISE; AULT, JOSEPH M.; BATEMAN, SIMON D.; PATEL, SUBASH; SIKORA, JOSEPH; YANG, REBECCA F.; ZIELINSKI, JOSEPH L.
To: NOVARTIS AG
Reel/Frame 017986/0077 →
SECURITY AGREEMENT Recorded Oct 3, 2005
From: EMISPHERE TECHNOLOGIES, INC.
To: MHR INSTITUTIONAL PARTNERS IIA LP
Reel/Frame 016617/0145 →